Vitrolife AB (0YAY) Ratios
Vitrolife AB Ratios
GB:0YAY's free cash flow for Q3 2026 was $189.00M. For the 2026 fiscal year, GB:0YAY's free cash flow was decreased by $-35.00M and operating cash flow was $224.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.40 | 3.34 | 3.44 | 2.53 | 1.47 |
| Quick Ratio | 2.73 | 2.74 | 2.69 | 1.88 | 1.15 |
| Cash Ratio | 1.32 | 1.61 | 1.55 | 0.93 | 0.66 |
| Solvency Ratio | -1.42 | 0.25 | -0.95 | 0.21 | 0.11 |
| Operating Cash Flow Ratio | 1.03 | 1.29 | 1.36 | 1.02 | 0.40 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 7.89 | 6.64 | 4.16 | 0.90 |
| Net Current Asset Value | $ -1.14B | $ -1.45B | $ -1.69B | $ -2.24B | $ -2.68B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.12 | 0.13 | 0.11 | 0.13 |
| Debt-to-Equity Ratio | 0.20 | 0.15 | 0.16 | 0.13 | 0.16 |
| Debt-to-Capital Ratio | 0.17 | 0.13 | 0.14 | 0.12 | 0.14 |
| Long-Term Debt-to-Capital Ratio | 0.16 | 0.12 | 0.13 | 0.11 | 0.11 |
| Financial Leverage Ratio | 1.41 | 1.28 | 1.28 | 1.23 | 1.27 |
| Debt Service Coverage Ratio | -65.46 | 2.78 | -15.39 | 3.92 | 1.06 |
| Interest Coverage Ratio | -70.07 | 7.18 | -35.19 | 10.90 | 43.54 |
| Debt to Market Cap | 0.08 | 0.07 | 0.08 | 0.08 | 0.04 |
| Interest Debt Per Share | 12.36 | 16.23 | 16.18 | 16.88 | 21.74 |
| Net Debt to EBITDA | -0.18 | 1.22 | -0.39 | 1.69 | 3.20 |
| Profitability Margins | |||||
| Gross Profit Margin | 58.05% | 59.27% | 56.32% | 55.04% | 62.24% |
| EBIT Margin | -140.03% | 21.70% | -102.79% | 17.97% | 28.00% |
| EBITDA Margin | -127.62% | 21.70% | -90.69% | 30.21% | 34.48% |
| Operating Profit Margin | -140.55% | 21.70% | -102.19% | 20.22% | 25.90% |
| Pretax Profit Margin | -142.03% | 18.68% | -105.69% | 16.60% | 27.37% |
| Net Profit Margin | -145.73% | 14.21% | -109.65% | 12.18% | 20.29% |
| Continuous Operations Profit Margin | -145.73% | 14.24% | -109.65% | 12.18% | 20.44% |
| Net Income Per EBT | 102.60% | 76.11% | 103.74% | 73.37% | 74.14% |
| EBT Per EBIT | 101.05% | 86.08% | 103.43% | 82.11% | 105.65% |
| Return on Assets (ROA) | -45.06% | 2.94% | -23.58% | 1.92% | 1.76% |
| Return on Equity (ROE) | -63.50% | 3.76% | -30.27% | 2.35% | 2.23% |
| Return on Capital Employed (ROCE) | -46.01% | 4.68% | -22.76% | 3.28% | 2.36% |
| Return on Invested Capital (ROIC) | -45.82% | 3.53% | -22.55% | 2.39% | 1.72% |
| Return on Tangible Assets | -176.14% | 17.20% | -154.97% | 19.42% | 18.13% |
| Earnings Yield | -27.02% | 1.76% | -14.61% | 1.56% | 0.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.59 | 4.71 | 6.98 | 5.97 | 3.90 |
| Payables Turnover | 6.94 | 7.24 | 8.97 | 8.03 | 3.67 |
| Inventory Turnover | 3.49 | 3.48 | 3.71 | 3.59 | 2.03 |
| Fixed Asset Turnover | 6.68 | 8.43 | 10.06 | 10.17 | 5.05 |
| Asset Turnover | 0.31 | 0.21 | 0.22 | 0.16 | 0.09 |
| Working Capital Turnover Ratio | 2.20 | 2.40 | 3.04 | 4.61 | 1.99 |
| Cash Conversion Cycle | 131.33 | 131.95 | 109.86 | 117.40 | 174.08 |
| Days of Sales Outstanding | 79.47 | 77.57 | 52.28 | 61.17 | 93.63 |
| Days of Inventory Outstanding | 104.47 | 104.78 | 98.27 | 101.67 | 179.93 |
| Days of Payables Outstanding | 52.61 | 50.40 | 40.69 | 45.44 | 99.49 |
| Operating Cycle | 183.94 | 182.35 | 150.55 | 162.84 | 273.56 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.69 | 6.70 | 5.59 | 4.70 | 3.35 |
| Free Cash Flow Per Share | 3.40 | 6.70 | 4.71 | 4.05 | 2.81 |
| Dividend Paid and CapEx Coverage Ratio | 1.96 | 4.00 | 3.24 | 3.24 | 2.57 |
| Capital Expenditure Coverage Ratio | 3.63 | 9.86 | 6.36 | 7.31 | 6.15 |
| Operating Cash Flow Coverage Ratio | 0.40 | 0.43 | 0.36 | 0.29 | 0.15 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.25 | 0.22 | 0.20 | 0.23 |
| Free Cash Flow Yield | 2.48% | 3.12% | 2.42% | 2.18% | 0.50% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.70 | 56.73 | -6.85 | 63.99 | 188.24 |
| Price-to-Sales (P/S) Ratio | 5.39 | 8.07 | 7.51 | 7.80 | 38.19 |
| Price-to-Book (P/B) Ratio | 2.35 | 2.13 | 2.07 | 1.51 | 4.19 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 40.33 | 32.10 | 41.32 | 45.92 | 199.44 |
| Price-to-Operating Cash Flow Ratio | 29.22 | 32.10 | 34.82 | 39.64 | 167.03 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.50 | 0.01 | -31.67 | 15.06 |
| Enterprise Value Multiple | -4.41 | 38.40 | -8.66 | 27.49 | 113.94 |
| Enterprise Value | 19.35B | 30.07B | 27.59B | 26.86B | 66.04B |
| EV to EBITDA | -4.41 | 38.40 | -8.66 | 27.49 | 113.94 |
| EV to Sales | 5.62 | 8.33 | 7.86 | 8.30 | 39.29 |
| EV to Free Cash Flow | 42.06 | 33.15 | 43.24 | 48.92 | 205.19 |
| EV to Operating Cash Flow | 30.47 | 33.15 | 36.45 | 42.23 | 171.85 |
| Tangible Book Value Per Share | -2.83 | -6.07 | -8.28 | -13.16 | -19.25 |
| Shareholders’ Equity Per Share | 58.29 | 100.71 | 93.96 | 123.61 | 133.67 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.03 | 0.24 | -0.04 | 0.27 | 0.25 |
| Revenue Per Share | 25.40 | 26.65 | 25.94 | 23.89 | 14.66 |
| Net Income Per Share | -37.02 | 3.79 | -28.44 | 2.91 | 2.97 |
| Tax Burden | 1.03 | 0.76 | 1.04 | 0.73 | 0.74 |
| Interest Burden | 1.01 | 0.86 | 1.03 | 0.92 | 0.98 |
| Research & Development to Revenue | 0.03 | 0.03 | 0.06 | 0.04 | 0.07 |
| SG&A to Revenue | 0.38 | 0.34 | 0.12 | 0.12 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.13 | 1.77 | -0.20 | 1.18 | 0.84 |
Currency in SEK